| JXHL1100067 | 沙格列汀二甲双胍缓释片 | metformin hydrochloride;saxagliptin | Tablet, extended release | Chemical Drugs | Import Drug Application | 2011-03-29 | Bristol-Myers Squibb Company | Bristol-Myers Squibb Company | Certificate Issued | 2012-12-06 | view |
| JXHL1100065 | 沙格列汀二甲双胍缓释片 | metformin hydrochloride;saxagliptin | Tablet, extended release | Chemical Drugs | Import Drug Application | 2011-03-29 | Bristol-Myers Squibb Company | Bristol-Myers Squibb Company | Certificate Issued | 2012-12-06 | view |
| JXHL1100066 | 沙格列汀二甲双胍缓释片 | metformin hydrochloride;saxagliptin | Tablet, extended release | Chemical Drugs | Import Drug Application | 2011-03-29 | Bristol-Myers Squibb Company | Bristol-Myers Squibb Company | Certificate Issued | 2012-12-06 | view |
| JXHS1300101 | 沙格列汀二甲双胍缓释片(III) | metformin hydrochloride;saxagliptin | Tablet, extended release | Chemical Drugs | Import Drug Application | 2013-12-05 | AstraZeneca AB | AstraZeneca AB;Astrazeneca Pharmaceuticals Lp | Certificate Issued | 2017-05-22 | view |
| JXHS1300100 | 沙格列汀二甲双胍缓释片(II) | metformin hydrochloride;saxagliptin | Tablet, extended release | Chemical Drugs | Import Drug Application | 2013-12-05 | AstraZeneca AB | AstraZeneca AB;Astrazeneca Pharmaceuticals Lp | Certificate Issued | 2017-05-22 | view |
| JXHS1300099 | 沙格列汀二甲双胍缓释片(I) | metformin hydrochloride;saxagliptin | Tablet, extended release | Chemical Drugs | Import Drug Application | 2013-12-05 | AstraZeneca AB | AstraZeneca AB;Astrazeneca Pharmaceuticals Lp | Certificate Issued | 2017-05-22 | view |
| CXHL1401434 | 沙格列汀二甲双胍缓释片(I) | metformin hydrochloride;saxagliptin | Tablet, extended release | Chemical Drugs(3.2) | New Drug Application | 2014-11-17 | 正大天晴药业集团股份有限公司 | Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd | Certificate Issued | 2016-03-24 | view |
| CXHL1401435 | 沙格列汀二甲双胍缓释片(Ⅱ) | metformin hydrochloride;saxagliptin | Tablet, extended release | Chemical Drugs(3.2) | New Drug Application | 2014-11-17 | 正大天晴药业集团股份有限公司 | Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd | Certificate Issued | 2016-03-24 | view |
| JYHB1700741 | 沙格列汀二甲双胍缓释片(I) | metformin hydrochloride;saxagliptin | Tablet, extended release | Chemical Drugs | Supplementary Application | 2017-06-05 | 阿斯利康制药有限公司 | Astrazeneca Pharmaceutical Co Ltd;AstraZeneca AB;Astrazeneca Pharmaceuticals Lp | Certificate Issued | 2017-07-17 | view |
| JYHB1700743 | 沙格列汀二甲双胍缓释片(III) | metformin hydrochloride;saxagliptin | Tablet, extended release | Chemical Drugs | Supplementary Application | 2017-06-05 | 阿斯利康制药有限公司 | Astrazeneca Pharmaceutical Co Ltd;AstraZeneca AB;Astrazeneca Pharmaceuticals Lp | Certificate Issued | 2017-07-17 | view |
| JYHB1700742 | 沙格列汀二甲双胍缓释片(II) | metformin hydrochloride;saxagliptin | Tablet, extended release | Chemical Drugs | Supplementary Application | 2017-06-05 | 阿斯利康制药有限公司 | Astrazeneca Pharmaceutical Co Ltd;AstraZeneca AB;Astrazeneca Pharmaceuticals Lp | Certificate Issued | 2017-07-17 | view |
| JYHB1700835 | 沙格列汀二甲双胍缓释片(III) | metformin hydrochloride;saxagliptin | Tablet, extended release | Chemical Drugs | Supplementary Application | 2017-06-21 | 阿斯利康制药有限公司 | Astrazeneca Pharmaceutical Co Ltd;AstraZeneca AB;Astrazeneca Pharmaceuticals Lp | Certificate Issued | 2018-06-04 | view |
| JYHB1700837 | 沙格列汀二甲双胍缓释片(II) | metformin hydrochloride;saxagliptin | Tablet, extended release | Chemical Drugs | Supplementary Application | 2017-06-21 | 阿斯利康制药有限公司 | Astrazeneca Pharmaceutical Co Ltd;AstraZeneca AB;Astrazeneca Pharmaceuticals Lp | Certificate Issued | 2018-06-04 | view |
| JYHB1700836 | 沙格列汀二甲双胍缓释片(I) | metformin hydrochloride;saxagliptin | Tablet, extended release | Chemical Drugs | Supplementary Application | 2017-06-21 | 阿斯利康制药有限公司 | Astrazeneca Pharmaceutical Co Ltd;AstraZeneca AB;Astrazeneca Pharmaceuticals Lp | Certificate Issued | 2018-06-04 | view |
| JYHF1700055 | 沙格列汀二甲双胍缓释片(III) | metformin hydrochloride;saxagliptin | Tablet, extended release | Chemical Drugs | Supplementary Application | 2017-06-22 | 阿斯利康制药有限公司 | Astrazeneca Pharmaceutical Co Ltd;AstraZeneca AB;Astrazeneca Pharmaceuticals Lp | Certificate Issued | 2017-08-01 | view |
| JYHF1700057 | 沙格列汀二甲双胍缓释片(II) | metformin hydrochloride;saxagliptin | Tablet, extended release | Chemical Drugs | Supplementary Application | 2017-06-22 | 阿斯利康制药有限公司 | Astrazeneca Pharmaceutical Co Ltd;AstraZeneca AB;Astrazeneca Pharmaceuticals Lp | Certificate Issued | 2017-08-01 | view |
| JYHF1700056 | 沙格列汀二甲双胍缓释片(I) | metformin hydrochloride;saxagliptin | Tablet, extended release | Chemical Drugs | Supplementary Application | 2017-06-22 | 阿斯利康制药有限公司 | Astrazeneca Pharmaceutical Co Ltd;AstraZeneca AB;Astrazeneca Pharmaceuticals Lp | In Review | 2018-02-13 | view |
| JYHB1801265 | 沙格列汀二甲双胍缓释片(III) | metformin hydrochloride;saxagliptin | Tablet, extended release | Chemical Drugs | Supplementary Application | 2018-10-24 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd;AstraZeneca AB;Astrazeneca Pharmaceuticals Lp | Filed | 2018-10-25 | view |
| JYHB1801264 | 沙格列汀二甲双胍缓释片(II) | metformin hydrochloride;saxagliptin | Tablet, extended release | Chemical Drugs | Supplementary Application | 2018-10-24 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd;AstraZeneca AB;Astrazeneca Pharmaceuticals Lp | Filed | 2018-10-25 | view |
| JYHB1801263 | 沙格列汀二甲双胍缓释片(II) | metformin hydrochloride;saxagliptin | Tablet, extended release | Chemical Drugs | Supplementary Application | 2018-10-24 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd;AstraZeneca AB;Astrazeneca Pharmaceuticals Lp | Filed | 2018-10-25 | view |
